Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Cervical cancer is the second most frequent cancer among women worldwide and the most frequent cancer among women in Africa, Asia, and South America. 1 In the United States, where screening for cervical cancer is readily available, most women who are found to have cervical cancer were not screened regularly. 2 As a result, about 25 percent of patients with cervical cancer in the United States present with locally advanced disease (stage IIB through IVA according to the staging system of the International Federation of Gynecology and Obstetrics). 3 , 4 The ability of radiotherapy to cure locally advanced cervical cancer is limited by . . .